Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Japanese approval sought by Mochida for new DIC treatment

Nov. 16, 2001

Acetamide-based thrombin inhibitors synthesized at Merck & Co.

Nov. 14, 2001

Factor Xa inhibitor as a novel therapeutic agent in embolic stroke

Nov. 14, 2001

Adjunctive AR-C69931 with thrombolysis proves beneficial in canine thrombosis model

Nov. 13, 2001

Factor Xa inhibition by CI-1031 prevents the formation of and deaggregates thrombi in pig model

Nov. 13, 2001

Predictable, dose- and time-independent PK for Arixtra in young and elderly subjects

Nov. 12, 2001

Development of beraprost for intermittent claudication expected to be dropped

Oct. 17, 2001

GlycoDesign and Leo move new antithrombotics into clinical trials

Oct. 15, 2001

Phase II trial of Argatroban plus gpIIb/IIIa antagonists initiated in patients undergoing PCI

Oct. 10, 2001

Avigen's Coagulin-B gene therapy for hemophilia B trial on clinical hold

Oct. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...